Some Prostate Cancers Don't Need to be Treated
Men aged 65 and older who are diagnosed with a low-risk form of prostate cancer don't need to jump right into treatment. Delaying surgery and radiation doesn't pose added risk of death as long as the cancer is closely monitored.
New Test Detects Prostate Cancer More Accurately
A large clinical trial has demonstrated a new screening for prostate cancer that's more accurate than the tests currently available. In research conducted by Northwestern Medicine, the new PSA test reduced the number of false positives and pinpointed prostate cancer more precisely, particularly the aggressive form of the disease.
Diabetes Increases Risks of Cancer
A new study shows that avoiding or controlling diabetes may reduce risks of developing or dying from cancer.
Certain Prostate Cancer Tumors More Likely to Metastasize
Certain prostate tumors have the potential to become metastatic if not treated aggressively, according to new research from Dana-Farber Cancer Institute.
New Therapy May Halt Prostate Cancer
A new RNA therapy has been shown to prevent prostate-cancer stem cells from replicating, thanks to new research from University of Texas MD Anderson Cancer Center.
The Little Gene that Could
The protein known as SIRT1 -- known for its life-spanning effects -- has been shown to inhibit prostatic intraepithelial neoplasia (PIN), which often prefigures prostate cancer.
The ABCs About PSAs
Researchers at Duke Cancer Institute believe they have pinpointed why PSA (prostate-specific antigen) levels reflect cancer progression.
Jury's Still Out on Prostate Cancer Therapy
Interstitial brachytherapy may or may not hold advantages compared to other therapy options in men with localized prostate cancer, according to a new study.
Nanoparticle Treatment Targets Prostate Tumors
The cancer drug cisplatin can be more effectively administered once encapsulated in a nanoparticle that targets prostate tumor cells and activates upon arrival.
Crunches for Prostate Health?
Physical activity may play a vital role in longevity in men with prostate cancer, according to a new study from Harvard School of Public Health and the University of California, San Francisco.